The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT ID: NCT06353659
Last Updated: 2024-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60 participants
OBSERVATIONAL
2024-04-15
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06341062
Ultrasound to Evaluate Acute Kidney Injury
NCT06241417
Clinical Application of Quantitative Ultrasonographic Analysis in Early Kidney Injury
NCT05662774
Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury
NCT06156098
Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury
NCT02376712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation。
2. To explore the relationship between renal microcirculation and systemic hemodynamics。
3. To explore the value of quantitative evaluation of renal microcirculation changes by contrast-enhanced ultrasound in the diagnosis of acute kidney injury
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with acute kidney injury (AKI)
Patient diagnosed with AKI according to kidney disease improving global outcomes (KDIGO) 2012 criteria
Contrast-enhanced Ultrasound
Patients with acute kidney injury high risk factors (KDIGO 2012) will undergo a contrast-enhanced ultrasound within 24 hours of admission to the ICU
Patients without AKI
Patient diagnosed without AKI according to kidney disease improving global outcomes (KDIGO) 2012 criteria
Contrast-enhanced Ultrasound
Patients with acute kidney injury high risk factors (KDIGO 2012) will undergo a contrast-enhanced ultrasound within 24 hours of admission to the ICU
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Contrast-enhanced Ultrasound
Patients with acute kidney injury high risk factors (KDIGO 2012) will undergo a contrast-enhanced ultrasound within 24 hours of admission to the ICU
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First admission to ICU \< 24h after admission and expected ICU stay ≥48 hours
* Acute kidney injury risk factors (KDIGO 2012)
* Contrast-enhanced ultrasound
Exclusion Criteria
* Kidney transplantation or renal malignancy
* Terminal stage of malignant tumor
* Pregnancy
* Renal artery stenosis or renal vein thrombosis
* The quality of CEUS images is poor, and quantitative analysis cannot be performed
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cui Ligang
Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ligang Cui, Dr
Role: PRINCIPAL_INVESTIGATOR
Department of Ultrasound, Peking University Third Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M2024077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.